{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T10:00:43Z","timestamp":1789984843573,"version":"4.0.1"},"reference-count":47,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Background\/Objectives: The development of multifaceted excipients is a requirement of the pharmaceutical industry. This study aimed to develop a granular co-processed excipient for tablets and to evaluate it using the SeDeM expert system. Methods: Four granule formulations were developed via the powder layering technique, varying binder concentrations (15% and 20%) and filler types (microcrystalline cellulose and lactose), using sugar as the core. The granules obtained were evaluated utilising the SeDeM expert system. The unloaded granules were compressed to yield uncoated compacted granules, which were verified for dimensional parameters, mechanical properties, and disintegration ability. Results: Varying binder concentrations (15% and 20%) together with differences in filler\/disintegrant composition were associated with changes in particle-size distribution. During the SeDeM evaluation, E3 formulation exhibited good results in terms of parameter index (PI = 0.83), parameter profile index (PPI = 7.64), and Good Compressibility Index (GCI = 7.28). The recorded disintegration times were below 15 min for all compacted granules and complied with the Ph. Eur. 12 requirements for uncoated tablets. Conclusions: For granule development, variations in formulation composition, including binder concentration, were associated with differences in particle size and lubricity. The SeDeM expert system can be used in the preformulation studies to characterize powders or granule formulations from which uncoated tablets can be obtained, but there are several pharmacotechnical properties not included in the list of parameters that need to be analysed to comply with the industrial requirements.<\/jats:p>","DOI":"10.3390\/ph19091481","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T09:01:38Z","timestamp":1789981298000},"page":"1481","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of Novel Co-Processed Excipients for Direct Compression Using the Sediment Delivery Model (SeDeM) Expert System"],"prefix":"10.3390","volume":"19","author":[{"given":"Adriana","family":"Ciurba","sequence":"first","affiliation":[{"name":"Pharmaceutical Technology and Cosmetology Department, Faculty of Pharmacy, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Targu Mures, 38th Gheorghe Marinescu Street, 540142 Targu Mures, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Antonoaea","sequence":"additional","affiliation":[{"name":"Pharmaceutical Technology and Cosmetology Department, Faculty of Pharmacy, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Targu Mures, 38th Gheorghe Marinescu Street, 540142 Targu Mures, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Em\u0151ke Margit","family":"R\u00e9dai","sequence":"additional","affiliation":[{"name":"Pharmaceutical Technology and Cosmetology Department, Faculty of Pharmacy, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Targu Mures, 38th Gheorghe Marinescu Street, 540142 Targu Mures, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5272-0963","authenticated-orcid":false,"given":"Andrada","family":"Pintea","sequence":"additional","affiliation":[{"name":"Pharmaceutical Technology and Cosmetology Department, Faculty of Pharmacy, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Targu Mures, 38th Gheorghe Marinescu Street, 540142 Targu Mures, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cezara","family":"Pintea","sequence":"additional","affiliation":[{"name":"Pharmaceutical Technology and Cosmetology Department, Faculty of Pharmacy, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Targu Mures, 38th Gheorghe Marinescu Street, 540142 Targu Mures, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amalia-Adina","family":"Cojocariu","sequence":"additional","affiliation":[{"name":"Pharmaceutical Technology and Cosmetology Department, Faculty of Pharmacy, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Targu Mures, 38th Gheorghe Marinescu Street, 540142 Targu Mures, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0749-8545","authenticated-orcid":false,"given":"Magdalena","family":"B\u00eersan","sequence":"additional","affiliation":[{"name":"Grigore T. Popa University of Medicine and Pharmacy from Ias\u0327i, 16 Universit\u0103t\u0327ii Street, 700115 Ias\u0327i, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u0103d\u0103lina-Florentina","family":"Mihalcea","sequence":"additional","affiliation":[{"name":"Pharmaceutical Technology and Cosmetology Department, Faculty of Pharmacy, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Targu Mures, 38th Gheorghe Marinescu Street, 540142 Targu Mures, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7751-2766","authenticated-orcid":false,"given":"Robert-Alexandru","family":"Vlad","sequence":"additional","affiliation":[{"name":"Pharmaceutical Technology and Cosmetology Department, Faculty of Pharmacy, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Targu Mures, 38th Gheorghe Marinescu Street, 540142 Targu Mures, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,17]]},"reference":[{"key":"ref_1","unstructured":"(2026, March 04). International Pharmaceutical Excipients Council Federation (IPEC Federation). Available online: https:\/\/ipec-federation.org\/."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s43094-021-00253-z","article-title":"Application of SeDeM Expert System in the Development of Novel Directly Compressible Co-Processed Excipients via Co-Processing","volume":"7","author":"Salim","year":"2021","journal-title":"Future J. Pharm. Sci."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2174\/2589977512666200928113716","article-title":"SeDeM Expert System, an Innovative Tool for Developing Directly Compressible Tablets: A Review","volume":"13","author":"Singh","year":"2021","journal-title":"Curr. Drug Res. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"104750","DOI":"10.1016\/j.jddst.2023.104750","article-title":"Comparison between Polymeric Excipients Using SeDeM Expert System in Combination with Mathematical Modeling and Quality Control Tools","volume":"86","author":"Caraballo","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s11094-021-02413-0","article-title":"Application of the SeDeM Method for Optimization of Tablet Formulations (A Review)","volume":"55","author":"Kotsur","year":"2021","journal-title":"Pharm. Chem. J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e2210299X338978","DOI":"10.2174\/012210299X338978241015155050","article-title":"Expert Systems in Preformulation and Formulation Development with Special Reference to SeDeM System: An Innovative, Problem Solving, Intelligent and Optimization Algorithm Tool","volume":"2","author":"Shukla","year":"2024","journal-title":"Curr. Indian Sci."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Figuera-Figuera, A., Su\u00f1\u00e9-Pou, M., P\u00e9rez-Lozano, P., Garc\u00eda-Montoya, E., Amela-Navarro, J., and Su\u00f1\u00e9-Negre, J.M. (2023). SeDeM as a Tool to Validate Drug Substance Manufacturing Processes and Assess Scalability and Suitability for Direct Compression: Supplier Screening. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15082034"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.jsps.2021.07.012","article-title":"Pharmacotechnical and Analytical Preformulation Studies for Cannabidiol Orodispersible Tablets","volume":"29","author":"Vlad","year":"2021","journal-title":"Saudi Pharm. J."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1080\/03639045.2019.1634094","article-title":"Optimization of the Process Variables of Roller Compaction, on the Basis of Granules Characteristics (Flow, Mechanical Strength, and Disintegration Behavior): An Application of SeDeM-ODT Expert System","volume":"45","author":"Khan","year":"2019","journal-title":"Drug Dev. Ind. Pharm."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1080\/10837450.2017.1345941","article-title":"New Perspective to Develop Memantine Orally Disintegrating Tablet Formulations: SeDeM Expert System","volume":"23","author":"Oktay","year":"2018","journal-title":"Pharm. Dev. Technol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1515\/acph-2017-0017","article-title":"Application of SeDeM Expert Systems in Preformulation Studies of Pediatric Ibuprofen ODT Tablets","volume":"67","author":"Sipos","year":"2017","journal-title":"Acta Pharm."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Trisopon, K., Kittipongpatana, N., Wattanaarsakit, P., and Kittipongpatana, O.S. (2021). Formulation Study of a Co-Processed, Rice Starch-Based, All-in-One Excipient for Direct Compression Using the SeDeM-ODT Expert System. Pharmaceuticals, 14.","DOI":"10.3390\/ph14101047"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Saokham, P., Khonkarn, R., Tipduangta, P., Panraksa, P., and Trisopon, K. (2025). Development of Spray-Dried Mannitol\u2013Pregelatinized Rice Starch Using SeDeM-Based Approach for Direct Compressible Cetirizine Dihydrochloride Tablets. Pharmaceutics, 17.","DOI":"10.3390\/pharmaceutics17111409"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.ejpb.2008.01.020","article-title":"Application of the SeDeM Diagram and a New Mathematical Equation in the Design of Direct Compression Tablet Formulation","volume":"69","author":"Roig","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Vizureanu, P. (2011). SeDeM Diagram: A New Expert System for the Formulation of Drugs in Solid Form. Expert Systems for Human, Materials and Automation, InTech. Chapter 15.","DOI":"10.5772\/700"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Tasaltin, N., Sunday Nnamchi, P., and Saud, S. (2020). SeDeM-ODT Expert System: A Solution to Challenges in Characterization of Pharmaceutical Powders and Powdered Material. Advanced Functional Materials, IntechOpen.","DOI":"10.5772\/intechopen.87879"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ijpharm.2014.04.068","article-title":"New Classification of Directly Compressible (DC) Excipients in Function of the SeDeM Diagram Expert System","volume":"470","author":"Roig","year":"2014","journal-title":"Int. J. Pharm."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ijpharm.2013.11.029","article-title":"The Use of the SeDeM Diagram Expert System for the Formulation of Captopril SR Matrix Tablets by Direct Compression","volume":"461","author":"Sarrate","year":"2014","journal-title":"Int. J. Pharm."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"367","DOI":"10.4274\/tjps.galenos.2019.94840","article-title":"Evaluation of Lactose-Based Direct Tableting Agents\u2019 Compressibility Behavior Using a Compaction Simulator","volume":"17","author":"Onayo","year":"2020","journal-title":"Turk. J. Pharm. Sci."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Zhang, J., Wu, C.Y., Pan, X., and Wu, C. (2017). On Identification of Critical Material Attributes for Compression Behaviour of Pharmaceutical Diluent Powders. Materials, 10.","DOI":"10.3390\/ma10070845"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.xphs.2023.08.022","article-title":"Risks of Powder Flow Obstruction in Hopper and Bin Discharge in Solid Dosage Form Manufacture Should Be Predicted under the Active Stress State","volume":"113","author":"Salish","year":"2024","journal-title":"J. Pharm. Sci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3109\/03639045.2012.756007","article-title":"SeDeM Expert System a New Innovator Tool to Develop Pharmaceutical Forms","volume":"40","year":"2014","journal-title":"Drug Dev. Ind. Pharm."},{"key":"ref_23","unstructured":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) (2009). ICH Harmonised Guideline Q8(R2): Pharmaceutical Development, ICH. Available online: https:\/\/www.ich.org\/page\/quality-guidelines."},{"key":"ref_24","unstructured":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) (2005). ICH Harmonised Guideline Q9: Quality Risk Management, ICH. Available online: https:\/\/www.ich.org\/page\/quality-guidelines."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijpharm.2007.06.017","article-title":"Mechanism of Moisture Induced Variations in True Density and Compaction Properties of Microcrystalline Cellulose","volume":"346","author":"Sun","year":"2008","journal-title":"Int. J. Pharm."},{"key":"ref_26","unstructured":"European Directorate for the Quality of Medicines & HealthCare (EDQM) (2026, March 05). European Pharmacopoeia\u2014New Online-Only 12th Edition. Available online: https:\/\/www.edqm.eu\/en\/european-pharmacopoeia-new-online-only-12th-edition."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jddst.2017.03.014","article-title":"The Effect of Binder Concentration and Dry Mixing Time on Granules, Tablet Characteristics and Content Uniformity of Low Dose Drug in High Shear Wet Granulation","volume":"39","author":"Mahours","year":"2017","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"124290","DOI":"10.1016\/j.ijpharm.2024.124290","article-title":"Evaluation of Binders in Twin-Screw Wet Granulation\u2014Optimization of Tabletability","volume":"659","author":"Kleinebudde","year":"2024","journal-title":"Int. J. Pharm."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Vlad, R.-A., Pintea, C., Chirte\u0219, D.-A., Antonoaea, P., R\u00e9dai, E.M., Todoran, N., B\u00eersan, M., and Ciurba, A. (2023). The Influence of the Intergranular Superdisintegrant Performance on New Drotaverine Orodispersible Tablet Formulations. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15082147"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.jsps.2015.01.015","article-title":"The Practical Approach to the Evaluation of Methods Used to Determine the Disintegration Time of Orally Disintegrating Tablets (ODTs)","volume":"23","author":"Brniak","year":"2015","journal-title":"Saudi Pharm. J."},{"key":"ref_31","unstructured":"Food and Drug Administration (FDA) (2026, May 02). Guidance for Industry: Nonclinical Studies for the Safety Evaluation of Pharmaceutical Excipients, Available online: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/nonclinical-studies-safety-evaluation-pharmaceutical-excipients."},{"key":"ref_32","unstructured":"European Medicines Agency (EMA) (2007). Guideline on Excipients in the Dossier for Application for Marketing Authorisation of a Medicinal Product; Scientific Guideline EMEA\/CHMP\/QWP\/396951\/2006, European Medicines Agency. Available online: https:\/\/www.ema.europa.eu\/en\/excipients-dossier-application-marketing-authorisation-medicinal-product-scientific-guideline."},{"key":"ref_33","unstructured":"United States Pharmacopeia (2023). Silicified Microcrystalline Cellulose, United States Pharmacopeial Convention. USP\u2013NF."},{"key":"ref_34","first-page":"163","article-title":"Evaluating Flow Properties of Solids","volume":"72","author":"Carr","year":"1965","journal-title":"Chem. Eng."},{"key":"ref_35","first-page":"7","article-title":"Friction Conditions in a Mass of Metal Powder","volume":"3","author":"Hausner","year":"1967","journal-title":"Int. J. Powder Metall."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1208\/s12249-019-1320-4","article-title":"Application of the SeDeM Expert System in Studies for Direct Compression Suitability on Mixture of Rhodiola Extract and an Excipient","volume":"20","author":"Wan","year":"2019","journal-title":"AAPS PharmSciTech"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1080\/10837450.2017.1342657","article-title":"Development of Multiple-Unit Pellet System Tablets by Employing the SeDeM Expert Diagram System I: Pellets with Different Sizes","volume":"23","author":"Hamman","year":"2018","journal-title":"Pharm. Dev. Technol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jsps.2013.11.004","article-title":"Quality in the Pharmaceutical Industry\u2014A Literature Review","volume":"23","author":"Haleem","year":"2015","journal-title":"Saudi Pharm. J."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"AlSwayeh, R., Alvi, S.N., and Hammami, M.M. (2021). Quality Assessment of Nine Paracetamol 500 Mg Tablet Brands Marketed in Saudi Arabia. BMC Res. Notes, 14.","DOI":"10.1186\/s13104-021-05672-y"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/jps.2600590523","article-title":"Determination of Tablet Strength by the Diametral-Compression Test","volume":"59","author":"Fell","year":"1970","journal-title":"J. Pharm. Sci."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Vlad, R.-A., Antonoaea, P., Todoran, N., R\u00e9dai, E.-M., B\u00eersan, M., Muntean, D.-L., Imre, S., Hancu, G., Farcz\u00e1di, L., and Ciurba, A. (2022). Development and Evaluation of Cannabidiol Orodispersible Tablets Using a 23-Factorial Design. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14071467"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.2042-7158.1974.tb09261.x","article-title":"The Calculation of the Tensile Strength of Tablets","volume":"26","author":"Newton","year":"1974","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1208\/s12249-014-0104-0","article-title":"Fast Tablet Tensile Strength Prediction Based on Non-Invasive Analytics","volume":"15","author":"Halenius","year":"2014","journal-title":"AAPS PharmSciTech"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1515\/cipms-2015-0013","article-title":"Compressional, Mechanical and Release Properties of a Novel Gum in Paracetamol Tablet Formulations","volume":"27","author":"Adedokun","year":"2014","journal-title":"Curr. Issues Pharm. Med. Sci."},{"key":"ref_45","first-page":"14","article-title":"Influence of Formulation and Process Parameters on Pellet Production by Powder Layering Technique","volume":"1","author":"Nastruzzi","year":"2000","journal-title":"AAPS PharmSciTech"},{"key":"ref_46","unstructured":"United States Pharmacopeia (2024). <1174> Powder Flow. USP-NF, United States Pharmacopeial Convention."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Aleksi\u0107, I., Gli\u0161i\u0107, T., \u0106irin-Vara\u0111an, S., Djuris, M., Djuris, J., and Paroj\u010di\u0107, J. (2024). Evaluation of the Potential of Novel Co-Processed Excipients to Enable Direct Compression and Modified Release of Ibuprofen. Pharmaceutics, 16.","DOI":"10.3390\/pharmaceutics16111473"}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/19\/9\/1481\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T09:06:37Z","timestamp":1789981597000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/19\/9\/1481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,17]]},"references-count":47,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["ph19091481"],"URL":"https:\/\/doi.org\/10.3390\/ph19091481","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,17]]}}}